<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02146885</url>
  </required_header>
  <id_info>
    <org_study_id>NIH/LAMMP-2012-9158</org_study_id>
    <nct_id>NCT02146885</nct_id>
  </id_info>
  <brief_title>The Use of Diffuse Optical Spectroscopy to Characterize in Response to Weight-Loss Intervention</brief_title>
  <official_title>The Use of Diffuse Optical Spectroscopy to Characterize Adipose Tissue Oxygenation and Vascular Reactivity in Response to Weight-Loss Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beckman Laser Institute University of California Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The first step in any clinical intervention against obesity involves sustained lifestyle&#xD;
      changes. Researcher can use these strategies to beneficial the effects of weight and on&#xD;
      cardiovascular risk. The researcher develope methods for assessing the effectiveness use&#xD;
      optical technology to make such assessments, specifically in the area of fatty tissue can&#xD;
      predict the effectiveness of the intervention in causing weight reduction and treating&#xD;
      metabolic disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Optical technologies under development at the Beckman Laser Institute.&#xD;
&#xD;
      Diffuse Optical Spectroscopy Imaging is a method for studying absorption and scattering&#xD;
      (optical properties) of tissue in humans. It is related to near-infrared spectroscopy , but&#xD;
      allows for more quantitative and thorough measurements. The researcher use Diffuse Optical&#xD;
      Spectroscopy to measure fatty tissue, water, blood concentration level during weight loss&#xD;
      program to determine the effect of sustained changes in weight or relapses.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 8, 2013</start_date>
  <completion_date type="Actual">January 13, 2017</completion_date>
  <primary_completion_date type="Actual">January 13, 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Weight Control</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">21</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>Weight Control</arm_group_label>
    <description>Weight Control</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Weight Control</intervention_name>
    <description>Weight Control</description>
    <arm_group_label>Weight Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will be selected from University of California Irvine Medical Center&#xD;
        Department of Cardiology, preventive cardiology intervention program.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Body Mass Index greater than 25, overweight&#xD;
&#xD;
          -  Participation in Weight Loss program&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A medical history of myocardial infarction or cerebrovascular stroke&#xD;
&#xD;
          -  Pregnancy or planned pregnancy during the course of the study period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shaista Malik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beckman Laser Institute, UCI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beckman Laser Institute</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>May 19, 2014</study_first_submitted>
  <study_first_submitted_qc>May 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2014</study_first_posted>
  <last_update_submitted>April 1, 2021</last_update_submitted>
  <last_update_submitted_qc>April 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Beckman Laser Institute and Medical Center</investigator_full_name>
    <investigator_title>Shaista Malik, M.D., Assistant Professor-Cardiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

